Equillium (EQ) Operating Leases (2021 - 2026)

Equillium (EQ) posted quarterly Operating Leases of $251000.0 for Q1 2026, up 68.46% year-over-year from $149000.0 in Q1 2025, and down 29.49% quarter-over-quarter from $356000.0 in Q4 2025.

Equillium (EQ) Operating Leases (2021 - 2026) Analysis & Trends

Equillium (EQ) has reported Operating Leases for 6 consecutive years, with $251000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Operating Leases rose 68.46% year-over-year to $251000.0; the TTM figure through Mar 2026 stood at $251000.0 (up 68.46% YoY), while the FY2025 annual figure was $356000.0, up 90.37% from the prior year.
  • Operating Leases fell to $251000.0 in Q1 2026 per EQ's latest filing, from $356000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $1.1 million in Q1 2022 and bottomed at $109000.0 in Q2 2025.
  • Historically, Operating Leases has averaged $494588.2 across 5 years, with a median of $384000.0 in 2023.
  • Annual changes were most pronounced in 2024 — Operating Leases slumped 58.97% — and 2025, when it jumped 112.11%.
  • Equillium's Operating Leases stood at $824000.0 in 2022, then plunged by 53.4% to $384000.0 in 2023, then sank by 51.3% to $187000.0 in 2024, then jumped by 90.37% to $356000.0 in 2025, then dropped by 29.49% to $251000.0 in 2026.
  • Business Quant data shows EQ's Operating Leases at $251000.0 in Q1 2026, $356000.0 in Q4 2025, and $473000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Equillium 263.86 Mn 263.86 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 172,000.00
Mar 31, 2026 251,000.00
Dec 31, 2025 356,000.00
Sep 30, 2025 473,000.00
Jun 30, 2025 109,000.00
Mar 31, 2025 149,000.00
Dec 31, 2024 187,000.00
Sep 30, 2024 223,000.00
Jun 30, 2024 259,000.00
Mar 31, 2024 295,000.00
Dec 31, 2023 384,000.00
Sep 30, 2023 498,000.00
Jun 30, 2023 609,000.00
Mar 31, 2023 719,000.00
Dec 31, 2022 824,000.00
Sep 30, 2022 925,000.00
Jun 30, 2022 1.03 Mn
Mar 31, 2022 1.12 Mn
Dec 31, 2021 1.24 Mn